Literature DB >> 26476539

Apoptotic effects of salinomycin on human ovarian cancer cell line (OVCAR-3).

Fuat Kaplan1, Fulya Teksen2.   

Abstract

In this study, we studied the apoptotic and cytotoxic effects of salinomycin on human ovarian cancer cell line (OVCAR-3) as salinomycin is known as a selectively cancer stem cell killer agent. We used immortal human ovarian epithelial cell line (IHOEC) as control group. Ovarian cancer cells and ovarian epithelial cells were treated by different concentrations of salinomycin such as 0.1, 1, and 40 μM and incubated for 24, 48, and 72 h. Dimethylthiazol (MTT) cell viability assay was performed to determine cell viability and toxicity. On the other hand, the expression levels of some of the apoptosis-related genes, namely anti-apoptotic Bcl-2, apoptotic Bax, and Caspase-3 were determined by quantitative real-time polymerase chain reaction (qRT-PCR). Additionally, Caspase-3 protein level was also determined. As a result, we concluded that incubation of human OVCAR-3 by 0.1 μM concentration of salinomycin for 24 h killed 40 % of the cancer cells by activating apoptosis but had no effect on normal cells. The apoptotic Bax gene expression was upregulated but anti-apoptotic Bcl-2 gene expression was downregulated. Active Caspase-3 protein level was increased significantly (p < 0.05).

Entities:  

Keywords:  Apoptosis; Cell viability; Ovarian cancer; Salinomycin

Mesh:

Substances:

Year:  2015        PMID: 26476539     DOI: 10.1007/s13277-015-4212-6

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  25 in total

Review 1.  Potassium efflux during apoptosis.

Authors:  Il-Seon Park; Ja-Eun Kim
Journal:  J Biochem Mol Biol       Date:  2002-01-31

2.  Tetrazolium (MTT) assay for cellular viability and activity.

Authors:  D M Morgan
Journal:  Methods Mol Biol       Date:  1998

3.  Salinomycin overcomes ABC transporter-mediated multidrug and apoptosis resistance in human leukemia stem cell-like KG-1a cells.

Authors:  Dominik Fuchs; Volker Daniel; Mahmoud Sadeghi; Gerhard Opelz; Cord Naujokat
Journal:  Biochem Biophys Res Commun       Date:  2010-03-27       Impact factor: 3.575

4.  Salinomycin inhibits proliferation and induces apoptosis of human nasopharyngeal carcinoma cell in vitro and suppresses tumor growth in vivo.

Authors:  Danxin Wu; Yu Zhang; Jie Huang; Zirong Fan; Fengrong Shi; Senming Wang
Journal:  Biochem Biophys Res Commun       Date:  2013-12-12       Impact factor: 3.575

Review 5.  Biomarkers of apoptosis: release of cytochrome c, activation of caspase-3, induction of 8-hydroxy-2'-deoxyguanosine, increased 3-nitrotyrosine, and alteration of p53 gene.

Authors:  A W Abu-Qare; M B Abou-Donia
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2001 Jul-Sep       Impact factor: 6.393

Review 6.  Targeting apoptosis pathways in cancer therapy.

Authors:  Irene M Ghobrial; Thomas E Witzig; Alex A Adjei
Journal:  CA Cancer J Clin       Date:  2005 May-Jun       Impact factor: 508.702

7.  Salinomycin induces apoptosis and overcomes apoptosis resistance in human cancer cells.

Authors:  Dominik Fuchs; Andreas Heinold; Gerhard Opelz; Volker Daniel; Cord Naujokat
Journal:  Biochem Biophys Res Commun       Date:  2009-10-14       Impact factor: 3.575

8.  Cancer statistics, 2006.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Taylor Murray; Jiaquan Xu; Carol Smigal; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2006 Mar-Apr       Impact factor: 508.702

9.  Identification of selective inhibitors of cancer stem cells by high-throughput screening.

Authors:  Piyush B Gupta; Tamer T Onder; Robert A Weinberg; Eric S Lander; Guozhi Jiang; Kai Tao; Charlotte Kuperwasser
Journal:  Cell       Date:  2009-08-13       Impact factor: 41.582

Review 10.  Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics.

Authors:  J F Kerr; A H Wyllie; A R Currie
Journal:  Br J Cancer       Date:  1972-08       Impact factor: 7.640

View more
  7 in total

Review 1.  Salinomycin, as an autophagy modulator-- a new avenue to anticancer: a review.

Authors:  Jiang Jiang; Hailong Li; Eskandar Qaed; Jing Zhang; Yushu Song; Rong Wu; Xinmiao Bu; Qinyan Wang; Zeyao Tang
Journal:  J Exp Clin Cancer Res       Date:  2018-02-13

Review 2.  Ionophores: Potential Use as Anticancer Drugs and Chemosensitizers.

Authors:  Vivek Kaushik; Juan Sebastian Yakisich; Anil Kumar; Neelam Azad; Anand K V Iyer
Journal:  Cancers (Basel)       Date:  2018-09-27       Impact factor: 6.639

Review 3.  Ovarian cancer stem cells and targeted therapy.

Authors:  Vahideh Keyvani; Moein Farshchian; Seyed-Alireza Esmaeili; Hadi Yari; Meysam Moghbeli; Seyed-Reza Kazemi Nezhad; Mohammad Reza Abbaszadegan
Journal:  J Ovarian Res       Date:  2019-12-06       Impact factor: 4.234

4.  Salinomycin and Sulforaphane Exerted Synergistic Antiproliferative and Proapoptotic Effects on Colorectal Cancer Cells by Inhibiting the PI3K/Akt Signaling Pathway in vitro and in vivo.

Authors:  Fang Liu; Rong-Bin Lv; Yan Liu; Qian Hao; Shu-Jie Liu; Yuan-Yuan Zheng; Cui Li; Cheng Zhu; Min Wang
Journal:  Onco Targets Ther       Date:  2020-06-03       Impact factor: 4.147

5.  Overcoming Resistance to Platinum-Based Drugs in Ovarian Cancer by Salinomycin and Its Derivatives-An In Vitro Study.

Authors:  Marcin Michalak; Michał Stefan Lach; Michał Antoszczak; Adam Huczyński; Wiktoria Maria Suchorska
Journal:  Molecules       Date:  2020-01-26       Impact factor: 4.411

Review 6.  The role of the microbiome in ovarian cancer: mechanistic insights into oncobiosis and to bacterial metabolite signaling.

Authors:  Adrienn Sipos; Gyula Ujlaki; Edit Mikó; Eszter Maka; Judit Szabó; Karen Uray; Zoárd Krasznai; Péter Bai
Journal:  Mol Med       Date:  2021-04-01       Impact factor: 6.354

Review 7.  Metabolic Plasticity in Chemotherapy Resistance.

Authors:  Maria Andrea Desbats; Isabella Giacomini; Tommaso Prayer-Galetti; Monica Montopoli
Journal:  Front Oncol       Date:  2020-03-06       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.